VINC
Vincerx Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+3.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 14, 2024 | THOMAS TOM C · officer: See Remarks | A-Award | 31,250 | $0.55 |
| Aug 14, 2024 | THOMAS TOM C · officer: See Remarks | A-Award | 175,000 | $0.55 |
| Aug 14, 2024 | THOMAS TOM C · officer: See Remarks | A-Award | 93,750 | $0.55 |
| Aug 14, 2024 | THOMAS TOM C · officer: See Remarks | A-Award | 86,000 | $0.55 |
| Aug 14, 2024 | THOMAS TOM C · officer: See Remarks | A-Award | 58,000 | $0.55 |
| Aug 14, 2024 | THOMAS TOM C · officer: See Remarks | A-Award | 56,000 | $0.55 |
| Aug 14, 2024 | THOMAS TOM C · officer: See Remarks | A-Award | 55,250 | $0.55 |
| Aug 14, 2024 | Hamdy Ahmed MD · director, officer: Chief Executive Officer | A-Award | 53,254 | $0.55 |
| Aug 14, 2024 | Hamdy Ahmed MD · director, officer: Chief Executive Officer | A-Award | 146,746 | $0.55 |
| Aug 14, 2024 | Hamdy Ahmed MD · director, officer: Chief Executive Officer | A-Award | 127,500 | $0.55 |
| Aug 14, 2024 | Hamdy Ahmed MD · director, officer: Chief Executive Officer | A-Award | 90,000 | $0.55 |
| Aug 14, 2024 | Hamdy Ahmed MD · director, officer: Chief Executive Officer | A-Award | 60,000 | $0.55 |
| Aug 14, 2024 | Seelenberger Alexander A. · officer: Chief Financial Officer | A-Award | 200,000 | $0.55 |
| Aug 14, 2024 | Seelenberger Alexander A. · officer: Chief Financial Officer | A-Award | 31,250 | $0.55 |
| Aug 14, 2024 | Seelenberger Alexander A. · officer: Chief Financial Officer | A-Award | 93,750 | $0.55 |
| Aug 14, 2024 | Seelenberger Alexander A. · officer: Chief Financial Officer | A-Award | 86,000 | $0.55 |
| Aug 14, 2024 | Seelenberger Alexander A. · officer: Chief Financial Officer | A-Award | 58,000 | $0.55 |
| Aug 14, 2024 | Seelenberger Alexander A. · officer: Chief Financial Officer | A-Award | 56,000 | $0.55 |
| Aug 14, 2024 | Seelenberger Alexander A. · officer: Chief Financial Officer | A-Award | 55,250 | $0.55 |
| Aug 14, 2024 | Izumi Raquel E. · director, officer: See Remarks | A-Award | 41,250 | $0.55 |
| Aug 14, 2024 | Izumi Raquel E. · director, officer: See Remarks | A-Award | 123,750 | $0.55 |
| Aug 14, 2024 | Izumi Raquel E. · director, officer: See Remarks | A-Award | 90,000 | $0.55 |
| Aug 14, 2024 | Izumi Raquel E. · director, officer: See Remarks | A-Award | 76,500 | $0.55 |
| Aug 14, 2024 | Izumi Raquel E. · director, officer: See Remarks | A-Award | 60,000 | $0.55 |
| May 29, 2024 | Seelenberger Alexander A. · officer: Chief Financial Officer | A-Award | 31,250 | $7.38 |
| May 29, 2024 | Izumi Raquel E. · director, officer: See Remarks | A-Award | 41,250 | $7.38 |
| May 29, 2024 | THOMAS TOM C · officer: See Remarks | A-Award | 31,250 | $7.38 |
| May 29, 2024 | Hamdy Ahmed MD · director, officer: Chief Executive Officer | A-Award | 53,254 | $7.38 |
| May 28, 2024 | Salva Francisco D. · director | A-Award | 15,000 | $0.70 |
| May 28, 2024 | Druker Brian · director | A-Award | 15,000 | $0.70 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 14, 2024